Positive Results for Hexvix Phase III Clinical Trial in China Presented at the SIU 2023 Congress

Contributed by: PR Newswire

Tags

Photocure

More Like This

Photocure Partner Asieris announces New Drug Application acceptance for regulatory review of Hexvix in China

Photocure establishes Named Patient Program to provide access to Hexvix in South Africa

Photocure ASA: Results for the third quarter of 2023

Bladder Cancer: Long-Term Benefits of Blue Light Cystoscopy and Enhanced Detection with HD Technology Unveiled at AUA 2024

Photocure ASA: Results for the fourth quarter of 2023

Photocure ASA: Results for the third quarter of 2024

Photocure ASA: Results for the second quarter of 2024

New Health Economic analysis in France concludes there is insignificant cost difference between White Light and Blue Light Cystoscopy use when applying ccAFU guidelines